Oncology The fire and ice of oncolytic virotherapy In the language of immuno-oncology (IO), the terms “hot” and “cold” refer to tumours that are inflamed or non-inflamed, respectively.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
